Glenmede Trust Company »

Bioage Labs shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $269k 11k 24.51

More positions owned by Glenmede Trust Company

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Rusel 2500 Etf (SMMD)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Putnam Etf Trust Focused Lar Cap (PVAL)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for Glenmede Trust Company

Top funds holding Bioage Labs

AH Capital Management
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Jupiter Topco
Henderson Group
Octagon Capital Advisors
RA Capital Management
MPM Oncology Impact Management
Vanguard Capital Management
Polar Capital Holdings
Braidwell
Geode Capital Management
State Street Corporation
Sands Capital Ventures

View all funds holding Bioage Labs